Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CLNN
#4210
Clene Inc. - Common Stock
4.4
7
USD
-0.04%
Market Price
Sector:
Consumer Defensive
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-3.87%
Monthly Change
-10.06%
6 month change
-10.60%
Year Change
0.00%
Previous Close
4.6
5
Open
4.4
7
Low
4.4
7
High
4.4
7
Volume
2
Markets
US Stock Market
Consumer Defensive
Packaged Foods
CLNN
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
2024
Quarterly report, Q2 FY2024
2024.08.07
Clene Inc. quarterly report, Q2 FY2024
10-Q
Current report, Q2 FY2024
2024.06.18
Clene Inc. current report, Q2 FY2024
8-K
1
2
3
4
5
6
News
Clene Inc. (CLNN) Reports Q2 Loss, Beats Revenue Estimates
Microbot Medical Inc. (MBOT) Reports Q2 Loss, Lags Revenue Estimates
Lineage Cell (LCTX) Reports Q2 Loss, Lags Revenue Estimates
Are Medical Stocks Lagging C4 Therapeutics (CCCC) This Year?
Clene (CLNN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Are Medical Stocks Lagging BrightSpring Health Services, Inc. (BTSG) This Year?
Clene Inc. (CLNN) Reports Q1 Loss, Misses Revenue Estimates
BioHarvest Sciences Inc. (BHST) Reports Q1 Loss, Beats Revenue Estimates
Clene Inc. ten percent owner sells $161k in shares
Clene Inc. ten percent owner sells $256k in shares
FDA grants Clene in-person meeting to discuss ALS drug biomarker data
Clene secures $28 million in registered direct offering for ALS drug